文献速递先天性心脏病外科

杂交与Norwood手术在Fontan循环患者中的多中心比较

Multicenter comparison of hybrid and Norwood procedures in patients with Fontan circulation.
PubMed 文献 · J Thorac Cardiovasc Surg · 2026-05-02

本研究利用多中心Fontan结局注册数据库,经倾向性评分匹配比较杂交一期姑息术(HS1P)与Norwood手术患者。结论认为存活至Fontan完成的HS1P患者远期结局与Norwood相当。

要点

  • 5、10、15年无复合结局生存率HS1P为82.3%、74.5%、61.2%,Norwood为81.4%、69.5%、54.7%。
  • 心脏磁共振及超声参数在两组间无差异,包括肺动脉再干预。

核心结论

  • 在倾向性匹配的多中心队列中,存活至Fontan完成的HS1P患者其Fontan期结局及心脏磁共振表现与Norwood相当。

研究设计与样本

  • 利用Fontan Outcomes Registry using Clinical Examinations多中心数据库,纳入接受HS1P或Norwood手术的患者,进行倾向性评分匹配。

主要发现

  • Fontan术后中位随访14年(95%CI 13.0-15.1年,反向Kaplan-Meier法)。
  • 匹配队列中复合结局各组分及肺动脉再干预在两组间相似,心脏磁共振和超声参数无差异。
  • 未匹配队列(n=954)三组分析以Blalock-Thomas-Taussig分流为参照,HS1P与复合结局或其组分的校正风险无差异。

临床怎么用

  • 对于存活至Fontan完成的患者,HS1P可作为Norwood的替代策略之一,远期结局相当。
  • 需进一步纵向研究优化患者选择并改善长期结局。

局限性

  • 研究仅纳入存活至Fontan完成的患者,存在选择偏倚。
  • 为回顾性多中心注册研究,虽经倾向性评分匹配,仍可能存在未测量混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The hybrid stage 1 palliation (HS1P) procedure has been proposed as an alternative to the Norwood operation. We utilized a multicenter database to compare both strategies. METHODS: The Fontan Outcomes Registry using Clinical Examinations was queried for patients who underwent HS1P or Norwood. Propensity score matching was performed. Composite outcome (death, transplant listing, protein losing enteropathy, plastic bronchitis, atrial/ventricular tachyarrhythmia, or pulmonary artery reintervention) and cardiac magnetic resonance variables were compared. Secondary analyses compared between HS1P and shunt type (Sano vs Blalock-Thomas-Taussig). RESULTS: Two hundred twenty-eight patients were analyzed (76 HS1P, 152 Norwood) after exclusion and matching. Median follow-up after Fontan was 14 years (95% CI, 13.0-15.1 years) using the reverse Kaplan-Meier method. The freedom from composite outcome was 82.3%, 74.5%, and 61.2% for HS1P patients compared with 81.4%, 69.5%, and 54.7% for Norwood patients at 5-, 10-, and 15-year follow-ups, respectively (hazard ratio, 1.02; 95% CI, 0.62-1.70; P = .9305). Individual components of the composite outcome were also similar between HS1P and Norwood in the matched cohort, including pulmonary artery reintervention. Cardiac magnetic resonance and echocardiographic parameters did not differ between groups. In a 3-group analysis of the unmatched cohort (n = 954) using Blalock-Thomas-Taussig conduit as the reference, HS1P was not associated with differences in adjusted hazard for the composite outcome or its individual components compared with Blalock-Thomas-Taussig. CONCLUSIONS: HS1P in those who survived to Fontan completion had comparable Fontan era outcomes and cardiac magnetic resonance findings to Norwood in a propensity matched multicenter cohort. Further longitudinal work is essential to refine patient selection and to optimize long-term outcomes.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kobayashi K, Schiff M, Seese L, et al. Multicenter comparison of hybrid and Norwood procedures in patients with Fontan circulation. J Thorac Cardiovasc Surg. 2026. PMID: 42081973. doi:10.1016/j.jtcvs.2026.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。